======= MCM7 ======= == Gene Information == * **Official Symbol**: MCM7 * **Official Name**: minichromosome maintenance complex component 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4176|4176]] * **UniProt**: [[https://www.uniprot.org/uniprot/P33993|P33993]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MCM7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MCM7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600592|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:9305914}. |MCM| |Mg chelatase| |AAA 5| |single-stranded 3-5 DNA helicase activity| |pre-replicative complex assembly involved in cell cycle DNA replication| |pre-replicative complex assembly| |pre-replicative complex assembly involved in nuclear cell cycle DNA replication| |double-strand break repair via break-induced replication| |MCM complex| |DNA unwinding involved in DNA replication| |DNA strand elongation involved in DNA replication| |DNA strand elongation| |DNA replication origin binding| |DNA replication initiation| |cellular response to epidermal growth factor stimulus| |nuclear DNA replication| |cell cycle DNA replication| |response to epidermal growth factor| |DNA helicase activity| |double-strand break repair via homologous recombination| |recombinational repair| |single-stranded DNA binding| |nuclear chromosome, telomeric region| |DNA duplex unwinding| |chromatin| |DNA geometric change| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |DNA-dependent DNA replication| |double-strand break repair| |cellular response to xenobiotic stimulus| |protein-DNA complex assembly| |DNA replication| |DNA recombination| |protein-DNA complex subunit organization| |mitotic cell cycle phase transition| |cell cycle phase transition| |DNA conformation change| |response to xenobiotic stimulus| |cellular response to growth factor stimulus| |DNA repair| |response to growth factor| |cell population proliferation| |mitotic cell cycle process| |mitotic cell cycle| |DNA metabolic process| |cellular response to DNA damage stimulus| |cellular protein-containing complex assembly| |nucleolus| |cell cycle process| |response to drug| |chromosome organization| |cellular response to endogenous stimulus| |cell cycle| |DNA binding| |response to endogenous stimulus| |ATP binding| |protein-containing complex assembly| |regulation of phosphorylation| |cellular response to stress| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |protein-containing complex subunit organization| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-2.4| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|-2.16| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-1.99| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-1.94| |[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.91| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|-1.81| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-1.71| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.7| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|1.87| |[[:results:exp133|MKC9989 10μM R03 exp133]]|1.93| |[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|2.04| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|2.12| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|2.25| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.55| ^Gene^Correlation^ |[[:human genes:r:rps2|RPS2]]|0.454| |[[:human genes:g:golga8o|GOLGA8O]]|0.441| |[[:human genes:c:ccdc64b|CCDC64B]]|0.412| |[[:human genes:c:ccna2|CCNA2]]|0.411| |[[:human genes:r:rrm1|RRM1]]|0.407| |[[:human genes:r:rps19bp1|RPS19BP1]]|0.404| |[[:human genes:r:rpl6|RPL6]]|0.402| Global Fraction of Cell Lines Where Essential: 727/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|32/33| |central nervous system|53/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|20/21| |liver|20/20| |lung|73/75| |lymphocyte|16/16| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|22/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|28/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 579 * **Expression level (log2 read counts)**: 9.18 {{:chemogenomics:nalm6 dist.png?nolink |}}